Late endovascular treatment of acute ischemic stroke Endovascular treatment (EVT) has become the standard of care for patients with acute ischemic stroke (AIS) due to large-vessel occlusion of the anterior circulation within 6 hours after the onset of symptoms. The recently published DAWN and DEFUSE 3 trials have shown that EVT is also effective beyond 6 hours after the onset of symptoms in patients who have been selected on the basis of CT perfusion imaging. We describe three cases of patients in whom we considered 'late' EVT on the basis of the results of these trials. Two female patients, 56 and 66 years old, both with large hemispheric AIS, were treated with EVT, respectively 8 and 15 hours after the onset of symptoms. Both patients had good clinical outcomes. In the third patient, a 79-year-old male, we decided to refrain from treatment with EVT on the basis of CT perfusion imaging. We describe our considerations with respect to these treatment decisions, our interpretation of the results of the DAWN and DEFUSE 3 trials and the implications of these results for the organization of stroke logistics in the Netherlands.
Download full-text PDF |
Source |
---|
Langenbecks Arch Surg
January 2025
Department of Trauma Surgery, University Hospital Zurich, Rämistrasse 100, CH - 8091, Zurich, Switzerland.
Introduction: Blunt traumatic aortic injury (TAI) is a critical condition and a leading cause of mortality in trauma patients, often resulting from high-speed accidents. Thoracic endovascular aortic repair (TEVAR) has developed into the preferred therapeutic approach due to its minimally invasive nature and promising outcomes. This study evaluates the safety and efficacy of TEVAR for managing TAI over a 10-year period at a Level-1 trauma center.
View Article and Find Full Text PDFCurr Gastroenterol Rep
January 2025
Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons and New York- Presbyterian Morgan Stanley Children's Hospital, 630 West 168Th Street, New York, NY, PH17-105H10032, USA.
Purpose: To propose a gastrointestinal bleeding management algorithm that incorporates an endoscopic and imaging scoring system and specifies management of vascular complication from button battery ingestion.
Recent Findings: Button batteries (BB) are found in many electronic devices and ingestions are associated with serious complications especially in cases of unwitnessed ingestions, prolonged impaction, and in children less than 5 years of age. Gastrointestinal bleeding from BB related vascular injury is rare but often rapidly fatal, with a mortality rate as high as 81%.
Heart Lung Circ
January 2025
Division of Cardiovascular Research, School of Medcine, University of Dundee, Ninewells Hospital, Dundee, UK. Electronic address:
Background: Research suggests that although men have a higher cardiovascular disease (CVD) rate, women with CVD are more likely to experience a poorer prognosis, possibly owing to incorrect diagnosis and poorer treatment. A question not yet addressed is whether some of this inequality could be due to sex bias when selecting patients for operation.
Method: The participants were from the Scottish Heart Health Extended Cohort who had been admitted to hospital with a cardiovascular diagnosis over the study period.
J Neurointerv Surg
January 2025
Department of Interventional Neuroradiology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China
Basilar artery perforator aneurysms (BAPAs) are rare and may be occult on initial imaging due to their small size and susceptibility to intermittent thrombosis.1 2 Conventional treatments for aneurysms (eg, clipping or coiling) have proved challenging.3 Recently, endovascular electrocoagulation has been shown to be effective for BAPAs.
View Article and Find Full Text PDFJ Neurointerv Surg
January 2025
Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, Jilin, China
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!